PPCB
Propanc Biopharma, Inc.
Key Financials
Operating Income
$-57278131
↓ 3628.9%
Net Income
$-58923300
↓ 3136.6%
Total Assets
$19.6M
↑ 27028.9%
Total Liabilities
$5.7M
↑ 48.7%
Shareholders' Equity
$13.9M
↑ 468.0%
Cash & Equivalents
$4067.00
↑ 80.4%
EPS (Diluted)
$-14.85
↓ 74150.0%
Operating Cash Flow
$-405168.00
↑ 56.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14C | 8/5/2026 | View on SEC |
| EFFECT | 7/27/2026 | View on SEC |
| S-1 | 7/17/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| EFFECT | 4/20/2026 | View on SEC |
| CORRESP | 4/16/2026 | View on SEC |
| UPLOAD | 4/15/2026 | View on SEC |
| S-1 | 4/10/2026 | View on SEC |
| DEF 14C | 3/31/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PPCB |
| Company Name | Propanc Biopharma, Inc. |
| CIK | 1517681 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 61-03-9882-0780 |